Compositions, kits, and methods for the modulation of immune responses using galectin-1

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9206427
APP PUB NO 20090191182A1
SERIAL NO

12175227

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is based, in part, on the discovery that galectin-1 (Gal1) plays a role in immune disorders, including Hodgkin lymphoma. Accordingly, the invention relates to compositions, kits, and methods for detecting, characterizing, modulating, preventing, and treating immune disorders, e.g., Hodgkin lymphoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FUNDACION SALESVIAMONTE 2043 PISO 6 A - BUENOS AIRES C1056ABE
CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICIAS Y TECNICAS (CONICET)AV RIVADAVIA 1906 3 PISO OF 15 CP C1033AAW CIUDAD AUTONOMA DE BUENOS AIRES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Juszczynski, Przemyslaw Jamaica Plain, US 4 11
Kutok, Jeffery Natick, US 2 4
Ouyang, Jing Chestnut Hill, US 19 46
Rabinovich, Gabriel Ciudad de Buenos Aires, AR 7 33
Rodig, Scott Westwood, US 2 10
Shipp, Margaret A Wellesley, US 19 123

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00